RESUMO
Shiga-toxin producing Escherichia coli (STEC) is the etiologic agent of acute diarrhea, dysentery, and hemolytic-uremic syndrome (HUS). There is no approved vaccine for STEC infection in humans, and antibiotic use is contraindicated, as it promotes Shiga toxin production. In order to identify STEC-associated antigens and immunogenic proteins, outer membrane proteins (OMPs) were extracted from STEC O26:H11, O103, O113:H21, and O157:H7 strains, and commensal E. coli strain HS was used as a control. SDS-PAGE, two-dimensional-PAGE analysis, Western blot assays using sera from pediatric HUS patients and controls, and matrix-assisted laser desorption ionization-tandem time of flight analyses were used to identify 12 immunogenic OMPs, some of which were not reactive with control sera. Importantly, seven of these proteins have not been previously reported to be immunogenic in STEC strains. Among these seven proteins, OmpT and Cah displayed IgG and IgA reactivity with sera from HUS patients. Genes encoding these two proteins were present in a majority of STEC strains. Knowledge of the antigens produced during infection of the host and the immune response to those antigens will be important for future vaccine development.
Assuntos
Proteínas da Membrana Bacteriana Externa/metabolismo , Infecções por Escherichia coli/microbiologia , Proteínas de Escherichia coli/metabolismo , Regulação Bacteriana da Expressão Gênica/fisiologia , Escherichia coli Shiga Toxigênica/metabolismo , Anticorpos Antibacterianos , Proteínas da Membrana Bacteriana Externa/genética , Infecções por Escherichia coli/imunologia , Proteínas de Escherichia coli/genética , Genoma Bacteriano , Humanos , Imunoglobulina A , Imunoglobulina G , Escherichia coli Shiga Toxigênica/genéticaRESUMO
Background: Shigella sonnei gastroenteritis improves clinically and microbiologically with antibacterial treatment; however choosing a useful drug is a universal challenge because of in vitro susceptibility of S. sonnei frequently evolves to be resistant. Objective: To evaluate in vitro susceptibility of S. sonnei strains isolated from patients attending at the Chilean Región Metropolitana and to know the evolution that resistant patterns of S. sonnei have experienced. Material: In this study, the antimicrobial susceptibility profile of 277 isolates of Shigella sonnei was compared. The analyzed periods of time were: period I (1995-1997) 85 strains; period II (2004-2006) 92 strains and period III (2008-2009) 100 strains, in Santiago, Chile. The method performed to analyze susceptibility patterns was the disc diffusion (Kirby-Bauer). Results: The strains showed rates of resistance to ampicillin: period I, 85.8%; period II, 53.3%; period III, 100%, trimethoprim/sulfamethoxazole: period I, 50.5%; period, II 46.7%; period III, 100%, chloramphenicol: period I, 36.4%; period II, 12%; period III, 100% and tetracycline: period I, 38.8%; period II, 30.4%; period III, 100%. 98.9% of the strains showed susceptibility to quinolones. Significant differences were observed in patterns of antimicrobial resistance for both individuals and for multidrug resistance (≥ 3 antimicrobials) in the three periods (p < 0.001, χ2 test). Of all resistant strains, 17% were resistant to 1 or 2 antibiotics, while 65.7% showed a pattern of multidrug resistance; 100% of the period III strains presented multidrug resistance. Conclusion: These results showed the temporal resistance dynamics of S. sonnei circulating strains in the Chilean Región Metropolitana. Due to the endemic behavior of shigellosis in Chile, it is urgent to maintain permanent surveillance of antimicrobial resistance profiles to improve both prevention and treatment of shigellosis.
Introducción: La infección entérica producida por Shigella sonnei mejora clínicamente y microbiológicamente con antibioterapia; sin embargo, la elección del antimicrobiano es un problema universal pues la susceptibilidad in vitro de S. sonnei evoluciona frecuentemente hacia la resistencia. Objetivo: Evaluar la susceptibilidad in vitro a antimicrobianos de S. sonnei y conocer la evolución que han experimentado los patrones de resistencia de cepas aisladas de cuadros clínicos en pacientes de la Región Metropolitana, Chile. Material y Métodos: Se comparó el perfil de susceptibilidad a antimicrobianos, de 277 cepas clínicas de S. sonnei aisladas durante tres períodos: período I (1995-1997) 85 cepas; período II (2004-2006) 92 cepas y período III (2008-2009) 100 cepas, en Santiago, Chile. El perfil de susceptibilidad a antimicrobianos se determinó mediante test de difusión en agar. Resultados: Las tasas de resistencia de las cepas en los periodos I, II y III respectivamente fueron: ampicilina: 85,8%; 53,3%; 100%, cotrimoxazol: 50,5%; 46,7%; 100%, cloranfenicol: 36,4%; 12%; 100% y tetraciclina: 38,8%; 30,4%; 100%. El 98,9% de las cepas fue susceptible a quinolonas. Se observó diferencias significativas en los porcentajes de resistencia para antimicrobianos individuales y multi-resistencia (≥ 3 antimicrobianos) en los tres períodos (p < 0,001; Test de χ2). De las cepas resistentes, 17% presentó resistencia a uno ó dos antimicrobianos, 65,7% mostró multi-resistencia antimicrobiana. El 100% de las cepas del período III presentó multi-resistencia. Discusión: Estos resultados evidencian la dinámica temporal de la resistencia en cepas de S. sonnei circulantes en la Región Metropolitana. Dado que en Chile la shigelosis tiene un carácter endémico, es prioritario mantener una vigilancia constante de los perfiles de resistencia a antimicrobianos, para mejorar la prevención y el tratamiento de la shigelosis.
Assuntos
Humanos , Antibacterianos/farmacologia , Shigella sonnei/efeitos dos fármacos , Chile , Farmacorresistência Bacteriana Múltipla , Disenteria Bacilar/microbiologia , Testes de Sensibilidade Microbiana , Shigella sonnei/isolamento & purificação , Fatores de Tempo , População UrbanaRESUMO
BACKGROUND: We evaluated a dipstick test for rapid detection of Shigella sonnei on bacterial colonies, directly on stools and from rectal swabs because in actual field situations, most pathologic specimens for diagnosis correspond to stool samples or rectal swabs. METHODOLOGY/PRINCIPAL FINDINGS: The test is based on the detection of S. sonnei lipopolysaccharide (LPS) O-side chains using phase I-specific monoclonal antibodies coupled to gold particles, and displayed on a one-step immunochromatographic dipstick. A concentration as low as 5 ng/ml of LPS was detected in distilled water and in reconstituted stools in 6 minutes. This is the optimal time for lecture to avoid errors of interpretation. In distilled water and in reconstituted stools, an unequivocal positive reaction was obtained with 4 x 10(6) CFU/ml of S. sonnei. The specificity was 100% when tested with a battery of Shigella and different unrelated strains. When tested on 342 rectal swabs in Chile, specificity (281/295) was 95.3% (95% CI: 92.9% - 97.7%) and sensitivity (47/47) was 100%. Stool cultures and the immunochromatographic test showed concordant results in 95.5 % of cases (328/342) in comparative studies. Positive and negative predictive values were 77% (95% CI: 65% - 86.5%) and 100% respectively. When tested on 219 stools in Chile, Vietnam, India and France, specificity (190/198) was 96% (95% CI 92%-98%) and sensitivity (21/21) was 100%. Stool cultures and the immunochromatographic test showed concordant results in 96.3 % of cases (211/219) in comparative studies. Positive and negative predictive values were 72.4% (95% CI 56.1%-88.6%) and 100 %, respectively. CONCLUSION: This one-step dipstick test performed well for diagnosis of S. sonnei both on stools and on rectal swabs. These data confirm a preliminary study done in Chile.
Assuntos
Diarreia/diagnóstico , Fezes/microbiologia , Reto/microbiologia , Shigella sonnei/patogenicidade , Diarreia/microbiologia , Humanos , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Shigella sonnei/isolamento & purificaçãoRESUMO
We previously demonstrated the immunogenicity and tolerability of the serogroup B meningococcal vaccine, 4CMenB (Bexsero), in 11-17 y-olds randomized to receive 1, 2, or 3 doses at 1, 2, or 6 mo intervals. Participants in this extension study provided an additional blood sample 18-24 mo after last vaccine dose, to assess persistence of serum bactericidal activity with human complement (hSBA), and to compare with age-matched 4CMenB-naïve controls. In the original study, one month after one 4CMenB dose, 93% of subjects had seroprotective hSBA titers (≥4) against indicator serogroup B strains for individual vaccine antigens (fHbp, NadA and NZOMV), increasing to ~100% after two or three doses. After 18-24 mo, 62-73% of subjects given one dose had titers ≥4 against the three antigens, significantly lower rates than after two (77-94%) or three (86-97%) doses. Only proportions with titers ≥ 4 against NZOMV were significantly different between the two (77%) and three (90%, p < 0.0001) dose groups. These results confirm that two doses of 4CMenB, administered 1 to 6 mo apart, provide good levels of bactericidal activity against serogroup B meningococci, which were sustained at least 18-24 mo in over 64% of adolescents for all three tested vaccine-related antigens.
Assuntos
Anticorpos Antibacterianos/sangue , Vacinas Meningocócicas/administração & dosagem , Vacinas Meningocócicas/imunologia , Neisseria meningitidis/imunologia , Adolescente , Atividade Bactericida do Sangue , Criança , Proteínas do Sistema Complemento/imunologia , Feminino , Humanos , Masculino , Adulto JovemRESUMO
BACKGROUND: Shigella sonnei gastroenteritis improves clinically and microbiologically with antibacterial treatment; however choosing a useful drug is a universal challenge because of in vitro susceptibility of S. sonnei frequently evolves to be resistant. OBJECTIVE: To evaluate in vitro susceptibility of S. sonnei strains isolated from patients attending at the Chilean Región Metropolitana and to know the evolution that resistant patterns of S. sonnei have experienced. MATERIAL: In this study, the antimicrobial susceptibility profile of 277 isolates of Shigella sonnei was compared. The analyzed periods of time were: period I (1995-1997) 85 strains; period II (2004-2006) 92 strains and period III (2008-2009) 100 strains, in Santiago, Chile. The method performed to analyze susceptibility patterns was the disc diffusion (Kirby-Bauer). RESULTS: The strains showed rates of resistance to ampicillin: period I, 85.8%; period II, 53.3%; period III, 100%, trimethoprim/sulfamethoxazole: period I, 50.5%; period, II 46.7%; period III, 100%, chloramphenicol: period I, 36.4%; period II, 12%; period III, 100% and tetracycline: period I, 38.8%; period II, 30.4%; period III, 100%. 98.9% of the strains showed susceptibility to quinolones. Significant differences were observed in patterns of antimicrobial resistance for both individuals and for multidrug resistance (≥ 3 antimicrobials) in the three periods (p < 0.001, χ2 test). Of all resistant strains, 17% were resistant to 1 or 2 antibiotics, while 65.7% showed a pattern of multidrug resistance; 100% of the period III strains presented multidrug resistance. CONCLUSION: These results showed the temporal resistance dynamics of S. sonnei circulating strains in the Chilean Región Metropolitana. Due to the endemic behavior of shigellosis in Chile, it is urgent to maintain permanent surveillance of antimicrobial resistance profiles to improve both prevention and treatment of shigellosis.
Assuntos
Antibacterianos/farmacologia , Shigella sonnei/efeitos dos fármacos , Chile , Farmacorresistência Bacteriana Múltipla , Disenteria Bacilar/microbiologia , Humanos , Testes de Sensibilidade Microbiana , Shigella sonnei/isolamento & purificação , Fatores de Tempo , População UrbanaRESUMO
To understand the etiology of moderate-to-severe diarrhea among children in high mortality areas of sub-Saharan Africa and South Asia, we performed a comprehensive case/control study of children aged <5 years at 7 sites. Each site employed an identical case/control study design and each utilized a uniform comprehensive set of microbiological assays to identify the likely bacterial, viral and protozoal etiologies. The selected assays effected a balanced consideration of cost, robustness and performance, and all assays were performed at the study sites. Identification of bacterial pathogens employed streamlined conventional bacteriologic biochemical and serological algorithms. Diarrheagenic Escherichia coli were identified by application of a multiplex polymerase chain reaction assay for enterotoxigenic, enteroaggregative, and enteropathogenic E. coli. Rotavirus, adenovirus, Entamoeba histolytica, Giardia enterica, and Cryptosporidium species were detected by commercially available enzyme immunoassays on stool samples. Samples positive for adenovirus were further evaluated for adenovirus serotypes 40 and 41. We developed a novel multiplex assay to detect norovirus (types 1 and 2), astrovirus, and sapovirus. The portfolio of diagnostic assays used in the GEMS study can be broadly applied in developing countries seeking robust cost-effective methods for enteric pathogen detection.
Assuntos
Diarreia/microbiologia , Diarreia/parasitologia , África Subsaariana , Ásia Ocidental , Estudos de Casos e Controles , Cryptosporidium/isolamento & purificação , Diarreia/etiologia , Diarreia/virologia , Entamoeba histolytica/isolamento & purificação , Escherichia coli/isolamento & purificação , Giardia/isolamento & purificação , Humanos , Técnicas Imunoenzimáticas , Técnicas Microbiológicas/métodos , Estudos Multicêntricos como Assunto/métodos , Parasitologia/métodos , Reação em Cadeia da Polimerase , Garantia da Qualidade dos Cuidados de Saúde , Controle de Qualidade , Virologia/métodos , Vírus/isolamento & purificaçãoRESUMO
BACKGROUND: Effective glycoconjugate vaccines against Neisseria meningitidis serogroups A, C, W-135, and Y have been developed, but serogroup B remains a major cause of severe invasive disease in infants and adolescents worldwide. We assessed immunogenicity and tolerability of a four-component vaccine (4CMenB) in adolescents. METHODS: We did a randomised, observer-blind, placebo-controlled, study at 12 sites in Santiago and Valparaíso, Chile. Adolescents aged 11-17 years received one, two, or three doses of 4CMenB at 1 month, 2 month, or 6 month intervals. Immunogenicity was assessed as serum bactericidal activity using human complement (hSBA) against three reference strains for individual vaccine antigens, and assessed by ELISA against the fourth strain. Local and systemic reactions were recorded 7 days after each vaccination, and adverse events were monitored throughout the study. Participants were initially randomised to five groups (3:3:3:3:1) during the primary phase to receive either one dose, two doses 1 or 2 months apart, or three doses of 4CMenB, or three doses of placebo, with an additional three groups generated for the booster phase. All subjects received at least one dose of 4CMenB. Geometric mean titres, proportions of participants with serum bactericidal antibody titres of 4 or more, and Clopper-Pearson 95% CIs were calculated. The study is registered with ClinicalTrials.gov, number NCT00661713. FINDINGS: Overall, 1631 adolescents (mean age 13·8 [SD 1·9] years) received at least one dose of 4CMenB. After two or three doses, 99-100% of recipients had hSBA titres of 4 or more against test strains, compared with 92-97% after one dose (p<0·0145) and 29-50% after placebo. At 6 months 91-100% of participants still had titres of 4 or more for each strain after two or three doses, but only 73-76% after one dose; seroresponse rates reached 99-100% for each strain after second or third doses at 6 months. Local and systemic reaction rates were similar after each 4CMenB injection and did not increase with subsequent doses, but remained higher than placebo. No vaccine-related serious adverse events were reported and no significant safety signals were identified. INTERPRETATION: On the basis of immunogenicity responses this study provides evidence for an adolescent 4CMenB vaccine schedule of two doses, 1-6 months apart, to provide protection against meningococcal B infection. The extent of this protection against meningococcus B variants circulating worldwide will be determined by national surveys. FUNDING: Novartis Vaccines and Diagnostics.
Assuntos
Infecções Meningocócicas/prevenção & controle , Vacinas Meningocócicas/efeitos adversos , Vacinas Meningocócicas/imunologia , Neisseria meningitidis Sorogrupo B/imunologia , Adolescente , Análise de Variância , Criança , Chile , Feminino , Humanos , Masculino , Infecções Meningocócicas/imunologia , Vacinas Meningocócicas/administração & dosagem , Método Simples-Cego , Resultado do Tratamento , Vacinação/métodosRESUMO
Enterotoxigenic Escherichia coli (ETEC) is an important cause of diarrhea. Three adhesins (Tia, TibA, EtpA), an iron acquisition system (Irp1, Irp2, and FyuA), a GTPase (LeoA), and an autotransporter (EatA) are ETEC virulence-related proteins that, in contrast to the classical virulence factors (enterotoxins and fimbrial colonization factors) have not heretofore been targets in characterizing isolates from epidemiological studies. Here, we determined the occurrence of these nonclassical virulence genes in 103 ETEC isolates from Chilean children with diarrhea and described their association with O serogroups and classical virulence determinants. Because tia, leoA, irp2, and fyuA are harbored by pathogenicity islands inserted into the selC and asnT tRNA genes (tDNAs), we analyzed the regions flanking these loci. Ten additional tDNAs were also screened to identify hot spots for genetic insertions. Associations between the most frequent serogroups and classical colonization factor (CF)-toxin profiles included O6/LT-STh/CS1-CS3-CS21 (i.e., O6 serogroup, heat-labile [LT] and human heat-stable [STh] enterotoxins, and CFs CS1, -3 and -21), O6/LT-STh/CS2-CS3-CS21, and O104-O127/STh/CFAI-CS21. The eatA and etpA genes were detected in more than 70% of the collection, including diverse serogroups and virulence profiles. Sixteen percent of the ETEC strains were negative for classical and nonclassical adhesins, suggesting the presence of unknown determinants of adhesion. The leuX, thrW, and asnT tDNAs were disrupted in more than 65% of strains, suggesting they are hot spots for the insertion of mobile elements. Sequences similar to integrase genes were identified next to the thrW, asnT, pheV, and selC tDNAs. We propose that the eatA and etpA genes should be included in characterizations of ETEC isolates in future epidemiological studies to determine their prevalence in other geographical regions. Sequencing of tDNA-associated genetic insertions might identify new ETEC virulence determinants.
Assuntos
Escherichia coli Enterotoxigênica/genética , Escherichia coli Enterotoxigênica/patogenicidade , Infecções por Escherichia coli/microbiologia , Ilhas Genômicas , Mutagênese Insercional , RNA de Transferência/genética , Fatores de Virulência/genética , Criança , Chile , DNA Bacteriano/química , DNA Bacteriano/genética , Diarreia/microbiologia , Escherichia coli Enterotoxigênica/isolamento & purificação , Proteínas de Escherichia coli/genética , Genética Microbiana/métodos , Humanos , Programas de Rastreamento/métodos , Dados de Sequência Molecular , Análise de Sequência de DNARESUMO
BACKGROUND: Rotavirus and more recently noroviruses are recognized as main causes of moderate to severe acute diarrhea episodes (ADE) in children < or =5 years of age. Comparing epidemiologic and clinical features of norovirus to rotavirus ADE will aid in the decision-making process required to develop norovirus vaccines. METHODS: Surveillance for ADE occurring in children < or =5 years of age was implemented in the emergency department (ED) and ward of a large hospital in Santiago and Valparaiso, and in 4 outpatient clinics in Santiago. A stool sample was obtained within 48 hours of consultation for rotavirus detection by enzyme-linked immunosorbent assay and noroviruses by enzyme-linked immunosorbent assay or reverse transcription polymerase chain reaction. For ED and hospital rotavirus and norovirus ADE parents were instructed to monitor clinical findings associated with severity until the end of the episode. The 20-point Vesikari score was used to determine disease severity. RESULTS: Between July 2006 and October 2008 rotavirus and noroviruses were detected in 331 (26%) and 224 (18%) of 1913 ADE evaluated. The proportion of rotavirus-positive samples in hospital ward, ED, and outpatient clinic was 40%, 26% to 30%, and 13% compared with 18%, 17% to 19%, and 14% for noroviruses. Mean age and 25%-75% interquartile interval of children with rotavirus and norovirus ADE were remarkably similar, 15.6 months (9-20), and 15.5 months (9-19), respectively. Rotavirus cases displayed an autumn-winter peak followed 2 to 3 months later by the norovirus peak. The mean (interquartile) for the Vesikari score was 12.9 (11-15) and 11.9 (9-14.5) for rotavirus (N = 331) and norovirus (N = 224) ADE, respectively, P = 0.003. Compared with norovirus, rotavirus ADE were more common in the 11 to 16 severity score interval (P = 0.006), had a higher maximum stool output in a given day (P = 0.01) and more frequent fever (P < 0.0001). Duration of diarrhea, presence, duration and intensity of vomiting, and intensity of fever did not differ between viruses. Mixed rotavirus and norovirus infections were uncommon (<1%) and not clinically more severe. Clinical severity of ADE in young infants was similar for rotavirus and lower (P = 0.03) for noroviruses compared with older children. CONCLUSION: Noroviruses are a significant cause of moderate to severe endemic ADE in Chilean children. Although significantly less severe than rotavirus as a group, most norovirus episodes were moderate to severe clinically. An effective norovirus vaccine would be of significant additional benefit to the current rotavirus vaccine in decreasing disease burden associated with ADE.
Assuntos
Infecções por Caliciviridae/epidemiologia , Infecções por Caliciviridae/patologia , Gastroenterite/epidemiologia , Gastroenterite/virologia , Infecções por Rotavirus/epidemiologia , Infecções por Rotavirus/patologia , Infecções por Caliciviridae/virologia , Pré-Escolar , Chile/epidemiologia , Diarreia/epidemiologia , Diarreia/patologia , Diarreia/virologia , Ensaio de Imunoadsorção Enzimática , Fezes/virologia , Feminino , Gastroenterite/patologia , Humanos , Lactente , Recém-Nascido , Masculino , Norovirus/isolamento & purificação , Estudos Prospectivos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Rotavirus/isolamento & purificação , Infecções por Rotavirus/virologia , Índice de Gravidade de DoençaRESUMO
Current methods to detect the colonization factor antigens (CFAs) associated with enterotoxigenic Escherichia coli (ETEC) strains are cumbersome, with some methods requiring antibodies that are not readily available. To achieve a gene-based method, we designed 2 multiplex polymerase chain reaction reactions to detect genes encoding the most common ETEC fimbrial colonization factors, including CFA/I and coli surface (CS) antigens CS1, CS2, CS3, CS4, CS5, and CS6. Analysis of 183 clinical ETEC strains shows that the most prevalent colonization factors were CFA/I only, CS1 and CS3, CS2 and CS3, and CS6 only. Interestingly, we identified 3 clinical isolates expressing CS1 only without its regulator rns. The method described here proved to be rapid and robust and correlates well with phenotypic expression of the CFAs, becoming a novel molecular diagnostic and research tool for future epidemiologic studies.
Assuntos
Escherichia coli Enterotoxigênica/imunologia , Infecções por Escherichia coli/microbiologia , Proteínas de Escherichia coli/genética , Proteínas de Fímbrias/genética , Reação em Cadeia da Polimerase/métodos , Pré-Escolar , Chile , Escherichia coli Enterotoxigênica/genética , Humanos , Epidemiologia Molecular/métodos , Sensibilidade e EspecificidadeRESUMO
BACKGROUND: Rotavirus and more recently norovirus have been recognized as 2 of the most common causes of acute diarrhea in children. Comparative analysis of these infections in a birth cohort has not been performed and can provide relevant insight on clinical and viral behaviors. METHODS: Mother-infant pairs from middle-low socioeconomic background living in the Metropolitan Region of Chile are being followed for 18 months in 2 outpatient clinics. Infants are evaluated monthly for asymptomatic excretion of rotavirus and norovirus and during acute diarrhea episodes (ADE) for rotavirus, norovirus, and bacterial enteropathogens. Severity of ADE is evaluated using the Vesikari score. RESULTS: Between July 1, 2006 and September 1, 2008 a total of 198 children were followed for a mean of 15.7 months. Asymptomatic rotavirus and norovirus infections were detected in 1.3% and 8% of 2278 stool samples compromising 14% and 57% of infants, respectively. Incidence of ADE was approximately 0.8 for the first year of life and approximately 0.6 for the 13 to 18 month age group. Rotavirus and norovirus were detected in 15% and 18% of 145 ADE evaluated. Mean Vesikari score was 10.4 and 7.4 for rotavirus and norovirus respectively (P = 0.01) and severity was not associated with age of patients for either virus. Reinfections were more common for norovirus asymptomatic episodes: 44% versus 19% (P = 0.01) and borderline for symptomatic episodes: 40% versus 11% (P = 0.08). Rotavirus genotype G9P8 and norovirus genogroup II (GII) predominated although most asymptomatic episodes for both viruses were nontypable. None of 19 symptomatic GII norovirus infections had a previous documented GII infection compared with 10 of 31 asymptomatic GII infections (OR = 0. 95% CL = 0, 0.59; P = 0.008). CONCLUSIONS: Children had suffered a mean of approximately 1.4 ADE by 18 months of age of which 15% and 18% were caused by rotavirus and norovirus, respectively. In general rotavirus infections were more severe than norovirus infections and for both viruses severity was not related to age. Norovirus reinfections were significantly more common than rotavirus reinfections but for GII norovirus a primary infection seems to confer protection against clinically significant reinfections.
Assuntos
Infecções por Caliciviridae/epidemiologia , Gastroenterite/epidemiologia , Norovirus/isolamento & purificação , Infecções por Rotavirus/epidemiologia , Rotavirus/isolamento & purificação , Infecções por Caliciviridae/patologia , Infecções por Caliciviridae/virologia , Chile/epidemiologia , Estudos de Coortes , Diarreia/epidemiologia , Diarreia/patologia , Diarreia/virologia , Fezes/virologia , Feminino , Gastroenterite/patologia , Gastroenterite/virologia , Humanos , Lactente , Recém-Nascido , Masculino , Norovirus/classificação , Norovirus/genética , Prevalência , Recidiva , Rotavirus/classificação , Rotavirus/genética , Infecções por Rotavirus/patologia , Infecções por Rotavirus/virologia , Índice de Gravidade de DoençaRESUMO
Adherence to epithelial cells by specific adhesins is a characteristic of Shiga toxin-producing Escherichia coli (STEC) strains. The eae-encoded protein intimin is the main adhesin implicated in intestinal colonization in vivo. We recently showed that STEC strains isolated in Chile displayed a wide variety of adhesins; here we demonstrate that some of these STEC strains are eae-negative and still adhere to epithelial cells at a level 100-fold higher than enterohaemorrhagic E. coli (EHEC) O157 : H7 prototype strain EDL933. This phenotype is associated with the presence of adherence factors different from the intimin protein. Subtractive hybridization between EHEC EDL933 and STEC eae-negative strain 472-1 was used to identify regions implicated in adhesion. In addition to the saa gene, we identified 18 specific genes in STEC 472-1, 16 of which had nucleotide identity to Salmonella ST46 phage genes; the two remaining ones shared identity to a gene encoding a hypothetical protein of uropathogenic E. coli. The DNA sequence of the STEC 472-1 psu-int region identified five open reading frames with homology to phage genes. We constructed mutant strains in the saa gene and the psu-int region to study the participation of these genes in the adherence to epithelial cells and our results demonstrated that STECDeltasaa and STECDeltapsu-int mutants displayed a 10-fold decrease in adherence as compared to the STEC 472-1 wild-type strain. Overall, our results suggest that STEC strain 472-1 adheres to epithelial cells in an eae-independent matter and that saa and psu-int participate in this adhesion process.
Assuntos
Adesinas Bacterianas/metabolismo , Adesinas de Escherichia coli/metabolismo , Proteínas de Escherichia coli/metabolismo , Hibridização de Ácido Nucleico/métodos , Escherichia coli Shiga Toxigênica/fisiologia , Adesinas Bacterianas/genética , Adesinas de Escherichia coli/química , Adesinas de Escherichia coli/genética , Aderência Bacteriana , Proteínas do Capsídeo/genética , Proteínas do Capsídeo/metabolismo , Linhagem Celular , Células Epiteliais/microbiologia , Escherichia coli O157/genética , Escherichia coli O157/metabolismo , Escherichia coli O157/fisiologia , Proteínas de Escherichia coli/química , Proteínas de Escherichia coli/genética , Humanos , Mutação , Escherichia coli Shiga Toxigênica/genética , Escherichia coli Shiga Toxigênica/metabolismoRESUMO
Capsid and polymerase (RdRp) genes of 13 norovirus outbreak strains from Chile were compared. The genes sequences were discordant for five strains, and recombination was confirmed for two of them by amplification of a 1,360-bp gene segment containing a fragment of both genes. These strains belonged to a novel genogroup by RdRp sequence and to genogroup GII/3 by capsid sequence. Determining the clinical and epidemiological impact of human calicivirus recombination will require future studies.
Assuntos
Surtos de Doenças , Gastroenterite/epidemiologia , Norovirus/genética , Recombinação Genética , Sequência de Bases , Infecções por Caliciviridae/epidemiologia , Infecções por Caliciviridae/virologia , Capsídeo , Proteínas do Capsídeo/genética , Chile/epidemiologia , RNA Polimerases Dirigidas por DNA/genética , Gastroenterite/virologia , Humanos , Dados de Sequência Molecular , FilogeniaRESUMO
We designed a multiplex PCR for the detection of all categories of diarrheagenic Escherichia coli. This method proved to be specific and rapid in detecting virulence genes from Shiga toxin-producing (stx(1), stx(2), and eae), enteropathogenic (eae and bfp), enterotoxigenic (st II and lt), enteroinvasive (vir F and ipa H), entero-aggregative (aaf II), and diffuse adherent (daa E) Escherichia coli in stool samples.
Assuntos
Diarreia/microbiologia , Infecções por Escherichia coli/microbiologia , Escherichia coli/classificação , Reação em Cadeia da Polimerase/métodos , Toxinas Bacterianas/genética , Toxinas Bacterianas/metabolismo , Criança , DNA Bacteriano/análise , Enterotoxinas/genética , Enterotoxinas/metabolismo , Escherichia coli/genética , Escherichia coli/patogenicidade , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , HumanosRESUMO
BACKGROUND: Cefpodoxime is a new antimicrobial in the Chilean market, recommended for treatment of respiratory and urinary tract infections. AIM: To study the susceptibility of common pathogens isolated from Chilean patients to cefpodoxime and other antimicrobials. MATERIAL AND METHODS: The in vitro activity of cefpodoxime, expressed as Minimal Inhibitory Concentration, was studied in 331 S pneumoniae, H influenzae, M catarrhalis, E coli, S aureus and S pyogenes strains, isolated between 2000 and 2004 from respiratory, urinary and soft tissue infections, respectively. RESULTS: Eleven percent of S pneumoniae isolates were resistant to penicillin, 11% were resistant to cefuroxime and 10% to cefpodoxime. All H influenzae isolates were susceptible to cefpodoxime. No H influenzae isolates were resistant to second or third generation cephalosporines. Four percent of H influenzae isolates were resistant to ampicillin by ss-lactamase production. In contrast 81% of M catarrhalis strains were resistant to ampicillin. Six percent of E coli isolates were resistant to cefpodoxime, 9% to cefuroxime, 11% to cefadroxile and 50% to ampicillin or trimethoprim/sulphamethoxazole. Cefpodoxime was the most active antimicrobial against S pyogenes. CONCLUSIONS: Cefpodoxime, recently introduced in Chile, is a good alternative for the treatment of common respiratory and urinary tract infections.
Assuntos
Antibacterianos/farmacologia , Ceftizoxima/análogos & derivados , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Positivas/efeitos dos fármacos , Ceftizoxima/farmacologia , Bactérias Gram-Negativas/isolamento & purificação , Bactérias Gram-Positivas/isolamento & purificação , Humanos , Testes de Sensibilidade Microbiana , CefpodoximaRESUMO
Human caliciviruses caused 45% of 55 gastroenteritis outbreaks occurring in Santiago, Chile, during 2000-2003. Outbreaks affected ?99 persons, occurred most commonly in the home, and were associated with seafood consumption. Thirteen outbreak strains sequenced were noroviruses, including 8 GII, 2 GI, and 3 belonging to a novel genogroup.
Assuntos
Infecções por Caliciviridae/epidemiologia , Infecções por Caliciviridae/virologia , Surtos de Doenças , Microbiologia de Alimentos , Gastroenterite/virologia , Adolescente , Adulto , Criança , Pré-Escolar , Chile/epidemiologia , Gastroenterite/epidemiologia , Humanos , Pessoa de Meia-Idade , Norovirus/genética , FilogeniaRESUMO
Variations in antibiotic resistance patterns were studied among 178 Shigella strains isolated from 1997 to 2001 in children less than five years of age with acute diarrhea from Colina, a semi-rural community in Santiago, Chile. The minimal inhibitory concentration of several commonly used antibiotics was determined by the agar dilution method. Shigella strains showed high rates of resistance to ampicillin (82%), cotrimoxazole (65%), tetracycline (53%), and chloramphenicol (49%). Furthermore, 51% of the strains showed resistance patterns to multiple antibiotics. Only 9% of the strains were resistant to amoxicillin-clavulanic acid and no resistance was observed to ciprofloxacin, nalidixic acid, or cefotaxime. Continuous monitoring of resistance patterns in Shigella is essential for establishing and updating guidelines for antibiotic treatment in shigellosis.
Assuntos
Resistência Microbiana a Medicamentos , Disenteria Bacilar/tratamento farmacológico , Vigilância da População , População Rural , Pré-Escolar , Chile/epidemiologia , Disenteria Bacilar/epidemiologia , Disenteria Bacilar/microbiologia , Humanos , Shigella/isolamento & purificação , Especificidade da EspécieRESUMO
More than one billion diarrhea episodes occur every year among children younger than 5 years of age in socioeconomically developing countries causing 2 to 2.5 million deaths. More than twenty viral, bacterial, and parasitic enteropathogens are currently associated with acute diarrhea. Rotavirus and diarrheagenic Escherichia coli are the most common pathogens responsible for acute diarrhea episodes in children; Shigella spp., Salmonella spp, Campylobacter jejuni/coli, Vibrio cholerae, Aeromonas spp, and Plesiomonas spp. occur more commonly in poorer areas and infections caused by protozoa and helminthes occur mainly in areas where environmental sanitation is significantly deteriorated. Initial clinical assessment of a child with diarrhea should focus on obtaining an accurate evaluation of hydration and nutritional status. Assessment of stool characteristics (e.g., liquid non-bloody stools vs. dysenteric or bloody stools) is a key feature in determining potential pathogens causing an acute diarrhea episode. Diagnostic guidelines are discussed in the article. The major therapeutic intervention for all individuals with diarrhea consists of fluid and electrolyte therapy. When antimicrobial therapy is appropriate, selection of a specific agent should be made based upon susceptibility patterns of the pathogen or information on local susceptibility patterns. Current guidelines for administering appropriate antimicrobial treatment are provided in the article. Preventive measures include careful personal hygiene, especially promotion of hand washing. Immunizations currently or soon to be available for Salmonella serotype Typhi, cholera prevention, and rotavirus are discussed.
Assuntos
Países em Desenvolvimento , Diarreia/epidemiologia , Doença Aguda , Animais , Pré-Escolar , Diarreia/etiologia , Diarreia/prevenção & controle , Diarreia/terapia , Escherichia coli/isolamento & purificação , Escherichia coli/patogenicidade , Eucariotos/isolamento & purificação , Eucariotos/patogenicidade , Humanos , Higiene , Imunização , Lactente , Rotavirus/isolamento & purificação , Rotavirus/patogenicidade , Saneamento , Higiene da PeleRESUMO
BACKGROUND: Streptococcus pneumoniae is a common etiologic agent of invasive respiratory infections among children under 5 years of age and older adults. Isolation rates of S. pneumoniae by traditional culture techniques are low. AIM: To study the sensitivity and specificity of two different DNA extraction methods to amplify the ply gene, applied to three different types of blood culture broths, experimentally inoculated with S. pneumoniae. MATERIAL AND METHODS: DNA was extracted from the cultures using an organic method or a technique that consists in dilution, washing with NaOH and concentration of the sample. This was followed by PCR amplification of a 355 pb fragment of the pneumolysin gene (ply). RESULTS: The organic DNA extraction method inhibited the PCR reaction at all concentrations studied (0.6 to 10(6) colony forming units/mL). Using the NaOH extraction, ply gene amplification was positive in all three blood culture broths, but only at concentrations of 10(3) colony forming units/mL, or higher. Using the same DNA extraction method, PCR was negative when the broths were inoculated with seven other related bacterial species, which results in a 100% specificity. CONCLUSIONS: Detection of S. pneumoniae by amplification of ply gene from blood cultures using the protocol of NaOH for DNA extraction is specific and provides results in a short lapse. However, the diagnostic sensitivity is not optimal, which limits its clinical use.
Assuntos
Proteínas de Bactérias/genética , DNA Bacteriano/isolamento & purificação , Reação em Cadeia da Polimerase , Streptococcus pneumoniae/isolamento & purificação , Estreptolisinas/genética , Técnicas Bacteriológicas , Meios de Cultura , DNA Bacteriano/genética , Infecções Pneumocócicas/diagnóstico , Reação em Cadeia da Polimerase/normas , Sensibilidade e Especificidade , Streptococcus pneumoniae/genéticaRESUMO
A multiplex PCR for detection of three categories of diarrheagenic Escherichia coli was developed. With this method, enterohemorrhagic E. coli, enteropathogenic E. coli, and enterotoxigenic E. coli were identified in fecal samples from patients with hemorrhagic colitis, watery diarrhea, or hemolytic-uremic syndrome and from food-borne outbreaks.